(NewsDirect)
BioVie chief social impact officer SarahHoit joined Steve Darling from Proactive to talk about the growingneed for support for individuals suffering from Alzheimer'sDisease and their caregivers, including family members.
Hoit emphasized that while research intoAlzheimer's treatments and cures is ongoing, it remains asignificant challenge. The quest for effective treatments andpotential cures is a critical aspect of addressing the Alzheimer'scrisis.
Hoit addressed how BioVieis helping on the clinical side with a very unique and differentapproach. Additionally, she shed light on the rising costs associatedwith Alzheimer's care, which have significant financialimplications for both healthcare systems and families.
The financial burden of Alzheimer'scare often falls on families, and the cost of care can be substantial.Moreover, the interview highlights the importance of brain healththroughout one's life, not just in seniors, and the role ofepigenetics in controlling around 70% of health outcomes.
Hoit also introduced Social ImpactPartners, a global brain health initiative, and encouragescollaboration between the private sector, nonprofits, and governmentsto combat the dementia crisis.
Overall, the discussionunderscored the urgent need for ongoing research, treatmentdevelopment, and support systems for individuals and families affectedby Alzheimer's disease.
ContactDetails
Proactive USA
+1 347-449-0879
na-editorial@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.